Dyslipidemia in adults with congenital heart disease: A systematic review and meta-analysis

Abstract

AimsSeveral particular characteristics of patients with congenital heart disease could affect lipid levels. The objectives of this study were: a) to analyze the prevalence of dyslipidemia in congenital heart disease patients; 2) to compare lipid levels between congenital heart disease patients and a control group. Data synthesisThis systematic review and meta-analysis was performed according to PRISMA guidelines (PROSPERO CRD42023432041). A literature search was performed to detect studies that have reported lipid levels or the prevalence of dyslipidemia in congenital heart disease patients. We performed a qualitative analysis (studies that reported dyslipidemia prevalence) and quantitative analysis (studies that compared lipid values between congenital heart disease patients and controls). In total, 29 observational studies involving 22,914 patients with congenital heart disease and 641,086 controls were eligible for this review. The reported presence of “hyperlipidemia” or “dyslipidemia” ranged from 14.3% to 69.9%. When studies analyzed lipid variables dichotomously between congenital heart disease patients and controls, the results were conflicting. The quantitative analysis showed that patients with congenital heart disease have lower levels of total cholesterol (MD: −18.9 [95% CI: −22.2 to −15.7]; I2 = 93%), LDL-C (MD: −10.7 [95% CI: −13.1 to −8.3]; I2 = 90%) and HDL-C (MD: −6.3 [95% CI: −7.7 to −4.9]; I2 = 95%) compared to controls. ConclusionsThe qualitative analysis showed some concerns, but the quantitative analysis indicates that congenital heart disease patients showed lower levels of total cholesterol, LDL-C, and HDL-C compared to controls. New research should be developed to clarify this relevant topic.